Another study reported the downregulation of miR-182 in five out of seven UM clinical specimens, showing that its tumor suppressive function depended on TP53 activation and regulated cell proliferation by targeting MITF, BCL2 (BCL2 apoptosis regulator), and CCND2. Here, TP53 is linked to neoplasm.